Clinical Trial Update: Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma [NA]

View source ↗

Summary

Clinical trial comparing VISCO360 to SLT in primary open-angle glaucoma was terminated. Results assessing safety and effectiveness have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Selective laser trabeculoplasty (SLT)
• VISCO360

Snippet

Sponsor: Sight Sciences, Inc. | Conditions: Open-Angle Glaucoma | NA | Status: TERMINATED | Results posted: 2025-09-24